Globus Medical (NYSE:GMED – Get Free Report) and Autonomix Medical (NASDAQ:AMIX – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations and institutional ownership.
Profitability
This table compares Globus Medical and Autonomix Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Globus Medical | 4.09% | 10.83% | 8.63% |
| Autonomix Medical | N/A | -212.48% | -161.13% |
Valuation & Earnings
This table compares Globus Medical and Autonomix Medical”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Globus Medical | $2.52 billion | 3.88 | $122.87 million | $0.75 | 94.67 |
| Autonomix Medical | N/A | N/A | -$15.43 million | ($12.93) | -0.13 |
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Globus Medical and Autonomix Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Globus Medical | 0 | 3 | 9 | 0 | 2.75 |
| Autonomix Medical | 0 | 0 | 1 | 0 | 3.00 |
Globus Medical currently has a consensus price target of $97.09, suggesting a potential upside of 36.74%. Autonomix Medical has a consensus price target of $28.00, suggesting a potential upside of 1,607.32%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Globus Medical.
Institutional and Insider Ownership
95.2% of Globus Medical shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 18.5% of Globus Medical shares are held by insiders. Comparatively, 32.4% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Volatility & Risk
Globus Medical has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -3.08, meaning that its share price is 408% less volatile than the S&P 500.
Summary
Globus Medical beats Autonomix Medical on 10 of the 13 factors compared between the two stocks.
About Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
About Autonomix Medical
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter.
